Added to YB: 2026-03-12
Pitch date: 2026-01-08
MLAB [bullish]
Mesa Laboratories, Inc.
-8.11%
current return
Author Info
No bio for this author
Company Info
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
Market Cap
$484.5M
Pitch Price
$84.68
Price Target
114.00 (+41%)
Dividend
0.73%
EV/EBITDA
12.76
P/E
128.91
EV/Sales
2.52
Sector
Life Sciences Tools and Services
Category
value
Mesa Laboratories, Inc. - $MLAB
MLAB: Sterilization testing & healthcare tools co at 8-9% FCF yield. Core SDC (41% rev, 60% EBITDA) & CS segments solid with MSD organic growth. Revenue accelerates to MSD in FY27 lapping China headwinds in Agena. Margin expansion from $2.3M cost cuts + operating leverage. Gyros ($180M paid) growing, Agena ($300M paid) potential sale/recovery adds upside. Target $114 (15x FY28 FCF of $7.62) vs $84 today = 35% return. Catalysts: debt reduction ($65M/$12/share over 2yr), IR launch, quarterly calls, active shareholders post S&P 600 deletion. Risks: bad M&A history, BD/CG execution, biologics shift.
Read full article (6 min)